BR9305557A - Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém - Google Patents

Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém

Info

Publication number
BR9305557A
BR9305557A BR9305557A BR9305557A BR9305557A BR 9305557 A BR9305557 A BR 9305557A BR 9305557 A BR9305557 A BR 9305557A BR 9305557 A BR9305557 A BR 9305557A BR 9305557 A BR9305557 A BR 9305557A
Authority
BR
Brazil
Prior art keywords
antibodies
rhesus
pharmaceutical composition
composition containing
human monoclonal
Prior art date
Application number
BR9305557A
Other languages
English (en)
Inventor
Roland Beliard
Ulf Bethke
Dominique Bourel
Ahmed Bouzidi
Herve Broly
Peter Byrne
Magali Houluigue
Michael Kloft
Detlef Rohm
Original Assignee
Aetsrn
Biotest Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9207893A external-priority patent/FR2692786B1/fr
Priority claimed from DE19924224357 external-priority patent/DE4224357C2/de
Application filed by Aetsrn, Biotest Pharma Gmbh filed Critical Aetsrn
Publication of BR9305557A publication Critical patent/BR9305557A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR9305557A 1992-06-26 1993-06-22 Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém BR9305557A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9207893A FR2692786B1 (fr) 1992-06-26 1992-06-26 Anticorps monoclonaux humains anti-rhesus d et lignees cellulaires les produisant.
DE19924224357 DE4224357C2 (de) 1992-07-23 1992-07-23 Arzneimittel zur Prophylaxe von HDN, enthaltend menschliche monoclonale anti-Rhesus (D)-Antikörper
PCT/EP1993/001591 WO1994000561A1 (en) 1992-06-26 1993-06-22 Human monoclonal anti-rhesus (d) antibodies and cell lines producing same

Publications (1)

Publication Number Publication Date
BR9305557A true BR9305557A (pt) 1997-03-25

Family

ID=25916870

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9305557A BR9305557A (pt) 1992-06-26 1993-06-22 Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém

Country Status (12)

Country Link
US (1) US5851524A (pt)
EP (1) EP0576093B1 (pt)
AT (1) ATE191006T1 (pt)
AU (1) AU678364B2 (pt)
BR (1) BR9305557A (pt)
CA (1) CA2116246A1 (pt)
DE (1) DE69328135D1 (pt)
FI (1) FI940811L (pt)
HU (1) HUT68624A (pt)
MX (1) MX9303839A (pt)
PL (1) PL302438A1 (pt)
WO (1) WO1994000561A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
FR2858235B1 (fr) 2003-07-31 2006-02-17 Lab Francais Du Fractionnement Utilisation d'anticorps optimises en adcc pour traiter les patients faibles repondeurs
FR2861078B1 (fr) * 2003-10-16 2007-09-21 Lab Francais Du Fractionnement NOUVELLES IgG3 UTILES POUR STIMULER LA PHAGOCYTOSE
US8288109B2 (en) 2004-07-20 2012-10-16 Symphogen A/S Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
EA014182B1 (ru) 2004-07-20 2010-10-29 Симфоген А/С КОМПОЗИЦИЯ ПОЛИКЛОНАЛЬНЫХ АНТИ-RhD АНТИТЕЛ, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ КОМПОЗИЦИИ
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
CN101679509A (zh) 2007-06-01 2010-03-24 弗·哈夫曼-拉罗切有限公司 免疫球蛋白纯化
CA2639003A1 (en) * 2008-08-20 2010-02-20 Canadian Blood Services Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations
JP2012513425A (ja) 2008-12-22 2012-06-14 エフ．ホフマン−ラ ロシュ アーゲー 免疫グロブリンの精製
US8821879B2 (en) 2009-09-04 2014-09-02 Xoma Technology Ltd. Anti-botulism antibody coformulations
US20110059079A1 (en) * 2009-09-04 2011-03-10 Xoma Technology Ltd. Antibody Coformulations
CN106267405B (zh) * 2016-07-01 2019-02-19 翁炳焕 母胎血型不合溶血病治疗仪

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
GB8722019D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722018D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722020D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8906129D0 (en) * 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations

Also Published As

Publication number Publication date
EP0576093B1 (en) 2000-03-22
FI940811A7 (fi) 1994-02-21
HUT68624A (en) 1995-07-28
AU678364B2 (en) 1997-05-29
EP0576093A1 (en) 1993-12-29
CA2116246A1 (en) 1994-01-06
PL302438A1 (en) 1994-07-25
US5851524A (en) 1998-12-22
DE69328135D1 (de) 2000-04-27
HU9400862D0 (en) 1994-06-28
WO1994000561A1 (en) 1994-01-06
FI940811A0 (fi) 1994-02-21
FI940811L (fi) 1994-02-21
AU4419793A (en) 1994-01-24
MX9303839A (es) 1994-08-31
ATE191006T1 (de) 2000-04-15

Similar Documents

Publication Publication Date Title
TR200002405T2 (tr) İnsan CD40' a karşı antikorlar
BR9305557A (pt) Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém
NL300433I1 (en) Methods and compositions for the treatment of glomerulonephritis
MX9707021A (es) Receptor de il-7.
GR3030141T3 (en) Diphtheria toxin receptor-binding region.
ATE169031T1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
IL124689A0 (en) Apoptosis induced by monoclonal antibody anti-her2
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
LU91271I2 (fr) Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI)
PL313260A1 (en) Monoclonal antibodies having properties making them able to cause apoptosis
HUT74674A (en) Use of modafinil for preparing pharmaceutica compositions for the treatment of sleep apnoea and ventilation problems of central origin
TW273514B (pt)
FR2794461B1 (fr) Procede de preparation de nouvelles fractions d'ig humaines possedant une activite immunomodulatrice
MY107079A (en) Method of reducing immunoglobulin e responses
SG48816A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
DE69007799D1 (de) Pharmazeutische antigen-antikörper-komplexe enthaltende zusammensetzungen und deren anwendungen.
ATE148348T1 (de) Behandlung von einer autoimmun-krankheit
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
ATE173504T1 (de) Granulozytenbindende antikörperkonstrukte, ihre herstellung und verwendung
ATE189122T1 (de) Monoklonale anti-idiotypische anti - ca125 antikörper und sie enthaltende pharmazeutische zusammensetzung
GB9224888D0 (en) Monoclonal antibody
HUP9700364A2 (hu) Fluidágyas reaktor hulladék hőkezelésére
DE69626642T2 (de) Cetp zur erhöhung des hdl-cholesterol-gehalts
HU9601392D0 (en) Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor
PL323195A1 (en) Alpha unit of human integrin beta 2

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal